id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0040-0004,FDA,FDA-2001-D-0040,"Guidance for Industry: Food-Effect Bioavailability and Fed Bioequivalence Studies: Study Design, Data Analysis, and Labeling",Other,Guidance,2019-06-19T04:00:00Z,2019,6,2019-06-19T04:00:00Z,,2019-06-19T16:27:53Z,,0,0,09000064804b6dba
FDA-2001-D-0040-0003,FDA,FDA-2001-D-0040,Guidance for Industry: Food-Effect Bioavailability and Fed Bioequivalence Studies,Other,Guidance,2019-06-19T04:00:00Z,2019,6,2019-06-19T04:00:00Z,,2019-06-19T16:26:37Z,,0,0,09000064804b6dff
FDA-2001-D-0040-0002,FDA,FDA-2001-D-0040,FDA,Notice,NAD-Notice of Availability of Data,2003-02-03T05:00:00Z,2003,2,,,2008-04-25T01:57:07Z,,0,0,09000064804b6e01
FDA-2001-D-0040-0001,FDA,FDA-2001-D-0040,FDA,Notice,NAD-Notice of Availability of Data,2001-11-29T05:00:00Z,2001,11,2001-11-29T05:00:00Z,2002-01-29T04:59:59Z,2008-04-25T01:57:07Z,,0,0,09000064804b6d71